Teleflex Gets FDA Clearance For ARROW Triple Lumen Pressure Injectable AHC

(RTTNews) - Teleflex Inc. (TFX) said that it has received FDA 510(k) clearance to market its ARROW Triple Lumen Pressure Injectable Acute Hemodialysis Catheter.

The ARROW Triple Lumen Pressure Injectable Acute Hemodialysis Catheter is available in the ARROW ErgoPack System, helping hospitals maintain compliance with current vascular access guidelines and standards while providing maximal barrier protection against infections when inserting these lines.

Teleflex is committed to partnering with healthcare facilities to reduce vascular access related complications. The ARROW Triple Lumen Pressure Injectable Acute Hemodialysis Catheter is another example of the Teleflex commitment to this goal.